Annual D&A
N/A
December 31, 2023
Summary
- ONCT annual depreciation & amortization is not available.
Performance
ONCT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 30, 2024
Summary
- ONCT quarterly depreciation & amortization is not available.
Performance
ONCT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 30, 2024
Summary
- ONCT TTM depreciation & amortization is not available.
Performance
ONCT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ONCT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ONCT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Oncternal Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$11.00 K(-200.0%) | $23.00 K(-50.0%) |
| Mar 2019 | - | $11.00 K(-8.3%) | $46.00 K(0.0%) |
| Dec 2018 | $46.00 K(-2.1%) | $12.00 K(+9.1%) | $46.00 K(0.0%) |
| Sep 2018 | - | $11.00 K(-8.3%) | $46.00 K(-2.1%) |
| Jun 2018 | - | $12.00 K(+9.1%) | $47.00 K(+2.2%) |
| Mar 2018 | - | $11.00 K(-8.3%) | $46.00 K(-2.1%) |
| Dec 2017 | $47.00 K(+67.9%) | $12.00 K(0.0%) | $47.00 K(+2.2%) |
| Sep 2017 | - | $12.00 K(+9.1%) | $46.00 K(+9.5%) |
| Jun 2017 | - | $11.00 K(-8.3%) | $42.00 K(+16.7%) |
| Mar 2017 | - | $12.00 K(+9.1%) | $36.00 K(+28.6%) |
| Dec 2016 | $28.00 K(-34.9%) | $11.00 K(+37.5%) | $28.00 K(+16.7%) |
| Sep 2016 | - | $8000.00(+60.0%) | $24.00 K(+4.3%) |
| Jun 2016 | - | $5000.00(+25.0%) | $23.00 K(-23.3%) |
| Mar 2016 | - | $4000.00(-42.9%) | $30.00 K(-30.2%) |
| Dec 2015 | $43.00 K(-57.8%) | $7000.00(0.0%) | $43.00 K(-17.3%) |
| Sep 2015 | - | $7000.00(-41.7%) | $52.00 K(-21.2%) |
| Jun 2015 | - | $12.00 K(-29.4%) | $66.00 K(-23.3%) |
| Mar 2015 | - | $17.00 K(+6.3%) | $86.00 K(-15.7%) |
| Dec 2014 | $102.00 K(-73.4%) | $16.00 K(-23.8%) | $102.00 K(-25.5%) |
| Sep 2014 | - | $21.00 K(-34.4%) | $137.00 K(-26.7%) |
| Jun 2014 | - | $32.00 K(-3.0%) | $187.00 K(-30.0%) |
| Mar 2014 | - | $33.00 K(-35.3%) | $267.00 K(-30.5%) |
| Dec 2013 | $384.00 K(-48.8%) | $51.00 K(-28.2%) | $384.00 K(-21.1%) |
| Sep 2013 | - | $71.00 K(-36.6%) | $487.00 K(-18.7%) |
| Jun 2013 | - | $112.00 K(-25.3%) | $599.00 K(-13.2%) |
| Mar 2013 | - | $150.00 K(-2.6%) | $690.00 K(-8.0%) |
| Dec 2012 | $750.00 K(-27.9%) | $154.00 K(-15.8%) | $750.00 K(-8.2%) |
| Sep 2012 | - | $183.00 K(-9.9%) | $817.00 K(-5.8%) |
| Jun 2012 | - | $203.00 K(-3.3%) | $867.00 K(-7.0%) |
| Mar 2012 | - | $210.00 K(-5.0%) | $932.00 K(-10.4%) |
| Dec 2011 | $1.04 M(-33.9%) | $221.00 K(-5.2%) | $1.04 M(-11.1%) |
| Sep 2011 | - | $233.00 K(-13.1%) | $1.17 M(-10.7%) |
| Jun 2011 | - | $268.00 K(-15.7%) | $1.31 M(-9.8%) |
| Mar 2011 | - | $318.00 K(-9.4%) | $1.45 M(-7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $1.57 M(-11.9%) | $351.00 K(-5.9%) | $1.57 M(-5.9%) |
| Sep 2010 | - | $373.00 K(-9.2%) | $1.67 M(-3.4%) |
| Jun 2010 | - | $411.00 K(-6.2%) | $1.73 M(-1.9%) |
| Mar 2010 | - | $438.00 K(-2.7%) | $1.76 M(-1.1%) |
| Dec 2009 | $1.78 M(+14.3%) | $450.00 K(+4.2%) | $1.78 M(-82.1%) |
| Sep 2009 | - | $432.00 K(-2.9%) | $9.99 M(+37.5%) |
| Jun 2009 | - | $445.00 K(-2.8%) | $7.26 M(+63.1%) |
| Mar 2009 | - | $458.00 K(-94.7%) | $4.45 M(+185.0%) |
| Dec 2008 | $1.56 M(+35.8%) | $8.65 M(-477.2%) | $1.56 M(-164.9%) |
| Sep 2008 | - | -$2.29 M(-3.0%) | -$2.41 M(+87.7%) |
| Jun 2008 | - | -$2.37 M(-2.7%) | -$1.28 M(+1263.8%) |
| Mar 2008 | - | -$2.43 M(-151.9%) | -$94.00 K(-108.2%) |
| Dec 2007 | $1.15 M(-123.0%) | $4.68 M(-500.3%) | $1.15 M(-114.3%) |
| Sep 2007 | - | -$1.17 M(-0.6%) | -$8.02 M(+9.8%) |
| Jun 2007 | - | -$1.18 M(-0.8%) | -$7.31 M(+18.6%) |
| Mar 2007 | - | -$1.19 M(-73.6%) | -$6.16 M(+23.1%) |
| Dec 2006 | -$5.01 M(+1574.9%) | -$4.49 M(+884.4%) | -$5.01 M(+787.9%) |
| Sep 2006 | - | -$456.00 K(+1371.0%) | -$564.00 K(+211.6%) |
| Jun 2006 | - | -$31.00 K(-3.1%) | -$181.00 K(-23.0%) |
| Mar 2006 | - | -$32.00 K(-28.9%) | -$235.00 K(-21.4%) |
| Dec 2005 | -$299.00 K(-48.4%) | -$45.00 K(-38.4%) | -$299.00 K(-30.9%) |
| Sep 2005 | - | -$73.00 K(-14.1%) | -$433.00 K(-54.4%) |
| Jun 2005 | - | -$85.00 K(-11.5%) | -$949.00 K(+33.5%) |
| Mar 2005 | - | -$96.00 K(-46.4%) | -$711.00 K(+22.6%) |
| Dec 2004 | -$580.00 K(-262.5%) | -$179.00 K(-69.6%) | -$580.00 K(+88.3%) |
| Sep 2004 | - | -$589.00 K(-485.0%) | -$308.00 K(-183.2%) |
| Jun 2004 | - | $153.00 K(+337.1%) | $370.00 K(+21.3%) |
| Mar 2004 | - | $35.00 K(-62.4%) | $305.00 K(-14.6%) |
| Dec 2003 | $357.00 K(+7.5%) | $93.00 K(+4.5%) | $357.00 K(+35.2%) |
| Sep 2003 | - | $89.00 K(+1.1%) | $264.00 K(+50.9%) |
| Jun 2003 | - | $88.00 K(+1.1%) | $175.00 K(+101.1%) |
| Mar 2003 | - | $87.00 K | $87.00 K |
| Dec 2002 | $332.00 K(+315.0%) | - | - |
| Dec 2000 | $80.00 K(+77.8%) | - | - |
| Dec 1999 | $45.00 K | - | - |
FAQ
- What is the all time high annual D&A for Oncternal Therapeutics?
- What is the all time high quarterly D&A for Oncternal Therapeutics?
- What is the all time high TTM D&A for Oncternal Therapeutics?
What is the all time high annual D&A for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual depreciation & amortization is $1.78 M
What is the all time high quarterly D&A for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly depreciation & amortization is $8.65 M
What is the all time high TTM D&A for Oncternal Therapeutics?
Oncternal Therapeutics all-time high TTM depreciation & amortization is $9.99 M